Association between proteinuria and left ventricular mass index: A cardiac MRI study in patients with chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 3, 2011, Pages 933-938

  McQuarrie, Emily P ^a   Patel, Rajan K ^a   Mark, Patrick B ^a   Delles, Christian ^a   Connell, John ^a   Dargie, Henry J ^a,b   Steedman, Tracey ^a,b   Jardine, Alan G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

cardiac MRI; cardiovascular; CKD; LVH; proteinuria

Indexed keywords

CREATININE; HEMOGLOBIN; PROTEIN; SODIUM;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY MASS; BODY SURFACE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPUTER PROGRAM; CREATININE URINE LEVEL; DEMOGRAPHY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PULSE PRESSURE; PULSE WAVE; SEX RATIO; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGED; BLOOD PRESSURE; COHORT STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROTEINURIA; RISK FACTORS;

EID: 79952138353     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq418     Document Type: Article

References (39)

1. Shlipak MG, Fried LF, Cushman M et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005;293:1737-1745
2. Levy J. Prote (Pubitemid 44365310)
3. Foley RN, Parfrey PS, Kent GM et al. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 2000;11:912-916 (Pubitemid 30241725)
4. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305
5. Patel RK, Oliver S, Mark PB et al. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging. Clin J Am Soc Nephrol 2009;4:1477-1483
6. Ruggenenti P, Perna A, Gherardi G et al. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis 2000;35:1155-1165 (Pubitemid 30354421)
7. de Zeeuw D, Remuzzi G, Parving HH et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004;65:2309-2320 (Pubitemid 38670018)
8. Tonelli M, Jose P, Curhan G et al. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 2006;332:1426
9. Jackson CE, Solomon SD, Gerstein HC et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009;374:543-550
10. deBoer IH, Katz R, Cao JJ et al. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diab Care 2009;32:1833-1838
11. Brown MJ, Palmer CR, Castaigne A et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000;356:366-372 (Pubitemid 30487492)
12. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426 (Pubitemid 32681484)
13. Kannel WB, Stampfer MJ, Castelli WP et al. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984;108:1347-1352 (Pubitemid 15210767)
14. Post WS, Blumenthal RS, Weiss JL et al. Spot urinary albumin-creatinine ratio predicts left ventricular hypertrophy in young hypertensive African-American men. Am J Hypertens 2000;13:1168-1172
15. Dell'omo G, Giorgi D, Di B et al. Blood pressure independent association of microalbuminuria and left ventricular hypertrophy in hypertensive men. J Intern Med 2003;254:76-84 (Pubitemid 36819132)
16. Wachtell K, Olsen MH, Dahlof B et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 2002;20:405-412 (Pubitemid 34913739)
17. Palmieri V, Tracy RP, Roman MJ et al. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diab Care 2003;26:2764-2769 (Pubitemid 37205544)
18. Alfakih K, Plein S, Thiele H et al. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003;17:323-329 (Pubitemid 36259246)
19. Mackinnon B, Fraser EP, Cattran DC et al. Validation of the Toronto formula to predict progression in IgA nephropathy. Nephron Clin Pract 2008;109: c148-c153 Ref Type: Generic
20. Joss N, Ferguson C, Brown C et al. Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy. QJM 2004;97:219-227 (Pubitemid 38489162)
21. Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009;4: S79-S91
22. Stewart GA, Gansevoort RT, Mark PB et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 2005;67:217-226 (Pubitemid 40019243)
23. Nardi E, Palermo A, Mule G et al. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 2009;27:633-641
24. Moran A, Katz R, Jenny NS et al. Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multiethnic study of atherosclerosis (MESA). Am J Kidney Dis 2008;52:839-848
25. Mark PB, Johnston N, Groenning BA et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006;69:1839-1845 (Pubitemid 43739213)
26. Olsen MH, Wachtell K, Borch-Johnsen K et al. A blood pressure independent association between glomerular albumin leakage and electrocardiographic left ventricular hypertrophy. The LIFE Study. Losartan Intervention For Endpoint reduction. J Hum Hypertens 2002;16:591-595 (Pubitemid 35021367)
27. Lieb W, Mayer B, Stritzke J et al. Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echocardiographic Substudy. Nephrol Dial Transplant 2006;21:2780-2787 (Pubitemid 44542231)
28. Nobakhthaghighi N, Kamgar M, Bekheirnia MR et al. Relationship between urinary albumin excretion and left ventricular mass with mortality in patients with type 2 diabetes. Clin J Am Soc Nephrol 2006;1:1187-1190
29. Shen WW, Chen HM, Chen H et al. Obesity-related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol 2010; May 24 [Epub ahead of print]
30. Windham BG, Griswold ME, Farasat SM et al. Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness. Am J Hypertens 2010;23:501-507
31. Ebinc H, Ebinc FA, Ozkurt ZN et al. Impact of adiponectin on left ventricular mass index in non-complicated obese subjects. Endocr J 2008;55:523-528 (Pubitemid 351949747)
32. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007;2:581-590
33. Desir GV. Regulation of blood pressure and cardiovascular function by renalase. Kidney Int 2009;76:366-370
34. Dieplinger B, Mueller T, Kollerits B et al. Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. Kidney Int 2009;75:408-414
35. Stefanski A, Schmidt KG, Waldherr R et al. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. Kidney Int 1996;50:1321-1326 (Pubitemid 26342825)
36. Bardaji A, Vea AM, Gutierrez C et al. Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 1998;32:970-975 (Pubitemid 28551159)
37. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-869 Ref Type: Generic
38. Kowey PR, Dickson TZ, Zhang Z et al. Losartan and end-organ protection-lessons from the RENAAL study. Clin Cardiol 2005;28:136-142 (Pubitemid 40364505)
39. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-1863